Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette
By A Mystery Man Writer
Description
A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://www.astctjournal.org/cms/attachment/28da1c37-539c-44fd-b179-96b04720f2e8/gr1_lrg.jpg)
Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy (GT): Updated Results in Group C Patients from the Phase 1/2 Hgb-206 Study - Biology of Blood and Marrow Transplantation
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg)
PDF) Editing Human DNA Moral and social implications of germline genetic modification
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://aholdencirm.files.wordpress.com/2018/03/brownfat_mice-e1521221433366.png)
gene therapy, The Stem Cellar
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://news.harvard.edu/wp-content/uploads/2015/09/sickle-cell-flickr-wellcome-images-_605.jpg)
Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://www.uchicagomedicine.org/-/media/images/ucmc/module-images/slider/pediatric-hematology/ucm_sc_infographic_web-06.png)
New study shows promising evidence for sickle cell gene therapy - UChicago Medicine
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://pbs.twimg.com/profile_images/877625245900976128/sGYNnt16_400x400.jpg)
Денис Савин (@withoutpassions) / X
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://i1.rgstatic.net/publication/338854778_Editing_Human_DNA_Moral_and_social_implications_of_germline_genetic_modification/links/5e2ff35b299bf10a65991e2b/largepreview.png)
PDF) Editing Human DNA Moral and social implications of germline genetic modification
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://d3i71xaburhd42.cloudfront.net/8f64c61d90940718b8591235a1fc458bfa73864e/2-Figure1-1.png)
PDF] Gene therapy for sickle cell disease: An update.
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://i0.wp.com/post.healthline.com/wp-content/uploads/2022/06/2271154-Gene-Therapy-for-Sick-Cell-Anemia_1296x900-body.png?w=1155&h=1890)
Sickle Cell Anemia and Gene Therapy: How It Works
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://img-cdn.thepublive.com/fit-in/1200x675/medriva/media/post_banners/content/uploads/2023/12/new-gene-therapies-for-sickle-cell-disease-20231215223530.jpg)
Gene Therapies for Sickle Cell Disease: A Promise Yet to Reach the Neediest
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://ars.els-cdn.com/content/image/1-s2.0-S0024320523008007-ga1.jpg)
CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects - ScienceDirect
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://news.harvard.edu/wp-content/uploads/2016/08/the_specialistsmri1.jpg)
Health Archives — Page 34 of 107 — Harvard Gazette
![Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette](https://news.harvard.edu/wp-content/uploads/2016/05/andy-myers1_061716-0001_605.jpg)
Health Archives — Page 34 of 107 — Harvard Gazette
from
per adult (price varies by group size)